Integrated Intervention for Breast Cancer Survivors With Diabetes

ID#: NCT05092477

Age: 55 years - 66+

Gender: Female

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: January 27, 2022

End Date: June 01, 2023

Contact Information:
Jaclyn Verity, MPH
Karisma Pantaleon, BS

The purpose of this research study is to learn how therapy for breast cancer or DCIS/LCIS affects cognitive function and beliefs about cancer/DCIS/LCIS and diabetes (DM). For this portion of the study, the study team will integrate the information collected at previous follow-ups to create educational modules to change disease and medication beliefs and improve DM self-management behaviors (SMB). The educational counseling modules the study team plans to pilot test are rooted in the Common Sense Self-Regulation Model, a theory that posits that health behaviors are influenced by two parallel processes: cognitive (i.e., disease beliefs and expectations) and affective (i.e., emotional responses).


Inclusion Criteria:

- An enrolled participant in the main observational study

- Completed 18-month follow-up interview

- Have at least 1 SMB target (Scored less than scored <4.5 on the MARS for DM, and/or <80% on objective adherence at 12-month (DM), and/or scored <4 on SDSCA)

- Must be willing to participate in the pilot intervention

Exclusion Criteria:

- Participant with suspected clinical depression on CESD (scored ≥20)